K Health, AI Primary Care, Raises $50M

 

K Health, the leading AI Primary Care platform, has announced today that it successfully secured $50M in funding led by Claure Group. Other investors who participated in this funding round include Pablo Legorreta, founder and CEO of Royalty Pharma, as well as existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.

Primary care plays a crucial role in the US healthcare system, as it is vital for enhancing clinical outcomes and reducing costs. With over a billion visits annually to primary and urgent care facilities, it is evident that access to high-quality longitudinal care is essential. However, challenges such as a shortage of physicians and fragmented point solutions have made it difficult for most individuals to access such care. While technology solutions have been implemented to reduce administrative burdens, they have not effectively addressed the core issue of providing personalized care at scale.

K Health stands out as the only company that has developed peer-reviewed, clinical-grade AI specifically for primary care. The company's co-pilot revolutionizes the primary care visit by guiding patients through a personalized chat, utilizing relevant EMRs to ground assessments, and providing providers with a comprehensive medical chart containing patient insights. This enables providers to make individualized diagnoses and treatments, freeing them to engage more deeply with patients, exercise clinical judgment, and establish follow-up care plans. By adopting this innovative model of care delivery through K's co-pilot, higher quality care can be achieved at lower costs compared to traditional primary care methods.

More Information : https://www.techdogs.com/tech-news/business-wire/k-health-the-leading-ai-primary-care-platform-raises-50-million-equity-funding-round